Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire

Abstract Backround The number of cancer survivors is growing steadily and increasingly, clinical trials are being designed to include long-term follow-up to assess not only survival, but also late effects and health-related quality of life (HRQOL). Therefore it is is essential to develop patient-rep...

Full description

Bibliographic Details
Main Authors: Marieke van Leeuwen, Olga Husson, Paola Alberti, Juan Ignacio Arraras, Olivier L. Chinot, Anna Costantini, Anne-Sophie Darlington, Linda Dirven, Martin Eichler, Eva B. Hammerlid, Bernhard Holzner, Colin D. Johnson, Meropi Kontogianni, Trille Kristina Kjær, Ofir Morag, Sandra Nolte, Andrew Nordin, Andrea Pace, Monica Pinto, Katja Polz, John Ramage, Jaap C. Reijneveld, Samantha Serpentini, Krzysztof A. Tomaszewski, Vassilios Vassiliou, Irma M. Verdonck-de Leeuw, Ingvild Vistad, Teresa E. Young, Neil K. Aaronson, Lonneke V. van de Poll-Franse, on behalf of the EORTC QLG
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12955-018-0920-0
_version_ 1811268671982534656
author Marieke van Leeuwen
Olga Husson
Paola Alberti
Juan Ignacio Arraras
Olivier L. Chinot
Anna Costantini
Anne-Sophie Darlington
Linda Dirven
Martin Eichler
Eva B. Hammerlid
Bernhard Holzner
Colin D. Johnson
Meropi Kontogianni
Trille Kristina Kjær
Ofir Morag
Sandra Nolte
Andrew Nordin
Andrea Pace
Monica Pinto
Katja Polz
John Ramage
Jaap C. Reijneveld
Samantha Serpentini
Krzysztof A. Tomaszewski
Vassilios Vassiliou
Irma M. Verdonck-de Leeuw
Ingvild Vistad
Teresa E. Young
Neil K. Aaronson
Lonneke V. van de Poll-Franse
on behalf of the EORTC QLG
author_facet Marieke van Leeuwen
Olga Husson
Paola Alberti
Juan Ignacio Arraras
Olivier L. Chinot
Anna Costantini
Anne-Sophie Darlington
Linda Dirven
Martin Eichler
Eva B. Hammerlid
Bernhard Holzner
Colin D. Johnson
Meropi Kontogianni
Trille Kristina Kjær
Ofir Morag
Sandra Nolte
Andrew Nordin
Andrea Pace
Monica Pinto
Katja Polz
John Ramage
Jaap C. Reijneveld
Samantha Serpentini
Krzysztof A. Tomaszewski
Vassilios Vassiliou
Irma M. Verdonck-de Leeuw
Ingvild Vistad
Teresa E. Young
Neil K. Aaronson
Lonneke V. van de Poll-Franse
on behalf of the EORTC QLG
author_sort Marieke van Leeuwen
collection DOAJ
description Abstract Backround The number of cancer survivors is growing steadily and increasingly, clinical trials are being designed to include long-term follow-up to assess not only survival, but also late effects and health-related quality of life (HRQOL). Therefore it is is essential to develop patient-reported outcome measures (PROMs) that capture the full range of issues relevant to disease-free cancer survivors. The objectives of this project are: 1) to develop a European Organisation for Research and Treatment of Cancer (EORTC) questionnaire that captures the full range of physical, mental and social HRQOL issues relevant to disease-free cancer survivors; and 2) to determine at which minimal time since completion of treatment the questionnaire should be used. Methods We reviewed 134 publications on cancer survivorship and interviewed 117 disease-free cancer survivors with 11 different types of cancer across 14 countries in Europe to generate an exhaustive, provisional list of HRQOL issues relevant to cancer survivors. The resulting issue list, the EORTC core questionnaire (QLQ-C30), and site-specific questionnaire modules were completed by a second group of 458 survivors. Results We identified 116 generic survivorship issues. These issues covered body image, cognitive functioning, health behaviors, negative and positive outlook, health distress, mental health, fatigue, sleep problems, physical functioning, pain, several physical symptoms, social functioning, and sexual problems. Patients rated most of the acute symptoms of cancer and its treatment (e.g. nausea) as no longer relevant approximately one year after completion of treatment. Conclusions Compared to existing cancer survivorship questionnaires, our findings underscore the relevance of assessing issues related to chronic physical side effects of treatment such as neuropathy and joint pain. We will further develop a core survivorship questionnaire and three site-specific modules for disease-free adult cancer survivors who are at least one year post-treatment.
first_indexed 2024-04-12T21:27:04Z
format Article
id doaj.art-bd2fa22b0abd4936aac49f46b734934a
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-04-12T21:27:04Z
publishDate 2018-06-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-bd2fa22b0abd4936aac49f46b734934a2022-12-22T03:16:08ZengBMCHealth and Quality of Life Outcomes1477-75252018-06-0116111510.1186/s12955-018-0920-0Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaireMarieke van Leeuwen0Olga Husson1Paola Alberti2Juan Ignacio Arraras3Olivier L. Chinot4Anna Costantini5Anne-Sophie Darlington6Linda Dirven7Martin Eichler8Eva B. Hammerlid9Bernhard Holzner10Colin D. Johnson11Meropi Kontogianni12Trille Kristina Kjær13Ofir Morag14Sandra Nolte15Andrew Nordin16Andrea Pace17Monica Pinto18Katja Polz19John Ramage20Jaap C. Reijneveld21Samantha Serpentini22Krzysztof A. Tomaszewski23Vassilios Vassiliou24Irma M. Verdonck-de Leeuw25Ingvild Vistad26Teresa E. Young27Neil K. Aaronson28Lonneke V. van de Poll-Franse29on behalf of the EORTC QLGDivision of Psychosocial Research & Epidemiology, The Netherlands Cancer InstituteDepartment of Medical Psychology, Radboud University Medical CenterExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-BicoccaOncology Departments, Complejo Hospitalario de NavarraPôle Neurosciences Cliniques, Service de Neuro-Oncologie, Aix-Marseille UniversitéDepartmental Psychoncology Unit, Sant’Andrea Hospital, Sapienza University of RomeFaculty of Health Sciences, University of SouthamptonDepartment of Neurology, Leiden University Medical CenterDivision of Epidemiology and Health Services Research at Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI)Department of Otolaryngology Head and Neck Surgery, Sahlgrenska University HospitalDepartment of Psychiatry and Psychotheraphy, Division of Psychooncology, Innsbruck Medical UniversityUniversity Surgical Unit, University Hospitals SouthamptonDepartment of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio UniversityUnit of Survivorship Research, Danish Cancer Society Research CenterOncology Institute, Chaim Sheba Medical CenterDepartment of Psychosomatic Medicine Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin BerlinEast Kent Gynaecological Oncology CentreNeuroncology Unit, National Cancer Institute Regina ElenaRehabilitation Unit, Department of Supportive Care, Istituto Nazionale Tumori – IRCCS- Fondazione G. PascaleEvangelische Kliniken GelsenkirchenDepartment of Gastroenterology and Hepatology, Hampshire Hospitals NHS Foundation TrustDepartment of Neurology and Brain Tumor Center Amsterdam, VU University Medical CenterUnit of Psychoncology - Breast Unit, Istituto Oncologico Veneto (IOV)-IRCCSHealth Outcomes Research Unit, Department of Geriatrics, Gerontology, and Social Work, Faculty of Education, Ignatianum AcademyDepartment of Radiation Oncology, Bank of Cyprus Oncology CentreDepartment of Otolaryngology / Head & Neck Surgery, VU University Medical CenterDepartment of Gynecology and Obstetrics, Sorlandet Hospital KristiansandLynda Jackson Macmillan Centre, East & North Hertfordshire NHS Trust including Mount Vernon Cancer CentreDivision of Psychosocial Research & Epidemiology, The Netherlands Cancer InstituteDivision of Psychosocial Research & Epidemiology, The Netherlands Cancer InstituteAbstract Backround The number of cancer survivors is growing steadily and increasingly, clinical trials are being designed to include long-term follow-up to assess not only survival, but also late effects and health-related quality of life (HRQOL). Therefore it is is essential to develop patient-reported outcome measures (PROMs) that capture the full range of issues relevant to disease-free cancer survivors. The objectives of this project are: 1) to develop a European Organisation for Research and Treatment of Cancer (EORTC) questionnaire that captures the full range of physical, mental and social HRQOL issues relevant to disease-free cancer survivors; and 2) to determine at which minimal time since completion of treatment the questionnaire should be used. Methods We reviewed 134 publications on cancer survivorship and interviewed 117 disease-free cancer survivors with 11 different types of cancer across 14 countries in Europe to generate an exhaustive, provisional list of HRQOL issues relevant to cancer survivors. The resulting issue list, the EORTC core questionnaire (QLQ-C30), and site-specific questionnaire modules were completed by a second group of 458 survivors. Results We identified 116 generic survivorship issues. These issues covered body image, cognitive functioning, health behaviors, negative and positive outlook, health distress, mental health, fatigue, sleep problems, physical functioning, pain, several physical symptoms, social functioning, and sexual problems. Patients rated most of the acute symptoms of cancer and its treatment (e.g. nausea) as no longer relevant approximately one year after completion of treatment. Conclusions Compared to existing cancer survivorship questionnaires, our findings underscore the relevance of assessing issues related to chronic physical side effects of treatment such as neuropathy and joint pain. We will further develop a core survivorship questionnaire and three site-specific modules for disease-free adult cancer survivors who are at least one year post-treatment.http://link.springer.com/article/10.1186/s12955-018-0920-0Cancer survivorDisease-freeHealth- related quality of lifeSurvivorship questionnaireDisease-freeOncology
spellingShingle Marieke van Leeuwen
Olga Husson
Paola Alberti
Juan Ignacio Arraras
Olivier L. Chinot
Anna Costantini
Anne-Sophie Darlington
Linda Dirven
Martin Eichler
Eva B. Hammerlid
Bernhard Holzner
Colin D. Johnson
Meropi Kontogianni
Trille Kristina Kjær
Ofir Morag
Sandra Nolte
Andrew Nordin
Andrea Pace
Monica Pinto
Katja Polz
John Ramage
Jaap C. Reijneveld
Samantha Serpentini
Krzysztof A. Tomaszewski
Vassilios Vassiliou
Irma M. Verdonck-de Leeuw
Ingvild Vistad
Teresa E. Young
Neil K. Aaronson
Lonneke V. van de Poll-Franse
on behalf of the EORTC QLG
Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
Health and Quality of Life Outcomes
Cancer survivor
Disease-free
Health- related quality of life
Survivorship questionnaire
Disease-free
Oncology
title Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
title_full Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
title_fullStr Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
title_full_unstemmed Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
title_short Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
title_sort understanding the quality of life qol issues in survivors of cancer towards the development of an eortc qol cancer survivorship questionnaire
topic Cancer survivor
Disease-free
Health- related quality of life
Survivorship questionnaire
Disease-free
Oncology
url http://link.springer.com/article/10.1186/s12955-018-0920-0
work_keys_str_mv AT mariekevanleeuwen understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT olgahusson understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT paolaalberti understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT juanignacioarraras understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT olivierlchinot understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT annacostantini understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT annesophiedarlington understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT lindadirven understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT martineichler understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT evabhammerlid understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT bernhardholzner understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT colindjohnson understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT meropikontogianni understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT trillekristinakjær understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT ofirmorag understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT sandranolte understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT andrewnordin understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT andreapace understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT monicapinto understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT katjapolz understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT johnramage understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT jaapcreijneveld understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT samanthaserpentini understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT krzysztofatomaszewski understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT vassiliosvassiliou understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT irmamverdonckdeleeuw understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT ingvildvistad understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT teresaeyoung understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT neilkaaronson understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT lonnekevvandepollfranse understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire
AT onbehalfoftheeortcqlg understandingthequalityoflifeqolissuesinsurvivorsofcancertowardsthedevelopmentofaneortcqolcancersurvivorshipquestionnaire